Literature DB >> 15186996

Regulation of plasma long-chain fatty acid oxidation in relation to uptake in human skeletal muscle during exercise.

Carsten Roepstorff1, Bodil Vistisen, Kirstine Roepstorff, Bente Kiens.   

Abstract

In the present study, we investigated possible sites of regulation of long-chain fatty acid (LCFA) oxidation in contracting human skeletal muscle. Leg plasma LCFA kinetics were determined in eight healthy men during bicycling (60 min, 65% peak oxygen uptake) with either high (H-FOX) or low (L-FOX) leg fat oxidation (H-FOX: 1,098 +/- 140; L-FOX: 494 +/- 84 micromol FA/min, P < 0.001), which was achieved by manipulating preexercise muscle glycogen (H-FOX: 197 +/- 21; L-FOX: 504 +/- 25 mmol/kg dry wt, P < 0.001). Several blood metabolites and hormones were kept nearly similar between trials by allocating a preexercise meal and infusing glucose intravenously during exercise. During exercise, leg plasma LCFA fractional extraction was identical between trials (H-FOX: 17.8 +/- 1.6; L-FOX: 18.2 +/- 1.8%, not significant), suggesting similar LCFA transport capacity in muscle. On the contrary, leg plasma LCFA oxidation was 99% higher in H-FOX than in L-FOX (421 +/- 47 vs. 212 +/- 37 micromol/min, P < 0.001). Probably due to the slightly higher (P < 0.01) plasma LCFA concentration in H-FOX than in L-FOX, leg plasma LCFA uptake was nonsignificantly (P = 0.17) higher (25%) in H-FOX than in L-FOX, yet the fraction of plasma LCFA uptake oxidized was 61% higher (P < 0.05) in H-FOX than in L-FOX. Accordingly, the muscle content of several lipid-binding proteins did not differ significantly between trials, although fatty acid translocase/CD36 and caveolin-1 were elevated (P < 0.05) by the high-intensity exercise and dietary manipulation allocated on the day before the experimental trial. The present data suggest that, in contracting human skeletal muscle with different fat oxidation rates achieved by manipulating preexercise glycogen content, transsarcolemmal transport is not limiting plasma LCFA oxidation. Rather, the latter seems to be limited by intracellular regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15186996     DOI: 10.1152/ajpendo.00001.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  8 in total

Review 1.  Caveolins in cardioprotection - translatability and mechanisms.

Authors:  Jan M Schilling; David M Roth; Hemal H Patel
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

Review 2.  Exercise-stimulated glucose uptake - regulation and implications for glycaemic control.

Authors:  Lykke Sylow; Maximilian Kleinert; Erik A Richter; Thomas E Jensen
Journal:  Nat Rev Endocrinol       Date:  2016-10-14       Impact factor: 43.330

Review 3.  Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise.

Authors:  Sebastian B Jørgensen; Erik A Richter; Jørgen F P Wojtaszewski
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

Review 4.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26

5.  The role of membrane fatty-acid transporters in regulating skeletal muscle substrate use during exercise.

Authors:  Maurice M A L Pelsers; Trent Stellingwerff; Luc J C van Loon
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

6.  Regulation of hormone-sensitive lipase activity and Ser563 and Ser565 phosphorylation in human skeletal muscle during exercise.

Authors:  Carsten Roepstorff; Bodil Vistisen; Morten Donsmark; Jakob N Nielsen; Henrik Galbo; Kevin A Green; D Grahame Hardie; Jørgen F P Wojtaszewski; Erik A Richter; Bente Kiens
Journal:  J Physiol       Date:  2004-08-12       Impact factor: 5.182

7.  Enhanced fatty acid oxidation and FATP4 protein expression after endurance exercise training in human skeletal muscle.

Authors:  Jacob Jeppesen; Andreas B Jordy; Kim A Sjøberg; Joachim Füllekrug; Andreas Stahl; Lars Nybo; Bente Kiens
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

8.  Niacin in pharmacological doses alters microRNA expression in skeletal muscle of obese Zucker rats.

Authors:  Aline Couturier; Janine Keller; Erika Most; Robert Ringseis; Klaus Eder
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.